Evan Y. Yu, MD, discusses the therapeutic options for metastatic castration-resistant prostate cancer (mCRPC) included in the National Comprehensive Cancer Network (NCCN) guidelines, such as ...
What are some new treatment options available now? The landscape of cancer treatment is rapidly evolving, particularly with the advent of groundbreaking immunotherapy options. At Memorial Sloan ...